Cargando…

Comment: In Response to “Megaloblastic Anemia with Ring Sideroblasts is not Always Myelodysplastic Syndrome”

Detalles Bibliográficos
Autor principal:	Gajendra, Smeeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2017
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451669/ https://www.ncbi.nlm.nih.gov/pubmed/27956372 http://dx.doi.org/10.4274/tjh.2016.0466

Ejemplares similares

Megaloblastic Anemia with Ring Sideroblasts is not Always Myelodysplastic Syndrome
por: Narang, Neha Chopra, et al.
Publicado: (2016)

Marrow iron staining should always be performed to diagnose Myelodysplastic/myeloproliferative neoplasia with ring sideroblasts and thrombocythemia.
por: Chauffaille, Maria de Lourdes Lopes Ferrari, et al.
Publicado: (2019)

Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
por: Komrokji, Rami S., et al.
Publicado: (2022)

Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS)
por: Ohba, Rie, et al.
Publicado: (2012)

Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis
por: Tefferi, A, et al.
Publicado: (2016)

Phrynoderma in a patient with megaloblastic anemia
por: Sharma, Vishal, et al.
Publicado: (2011)

Stroke as an Initial Manifestation of Thiamine-Responsive Megaloblastic Anemia
por: Madaan, Priyanka, et al.
Publicado: (2020)

Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts
por: Huber, Sandra, et al.
Publicado: (2022)

Comment on: Bilateral macular hemorrhage due to megaloblastic anemia: A rare case report
por: Goel, Neha
Publicado: (2016)

Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome
por: Májek, Pavel, et al.
Publicado: (2013)

Gaucher-like cells in myelodysplastic syndrome with ring sideroblasts
por: El Khoury, Christelle, et al.
Publicado: (2022)

Myelodysplastic syndrome/myeloproliferative neoplasm with ringed sideroblasts and thrombocytosis
por: Tasleem, Azka, et al.
Publicado: (2021)

Leukemoid reaction in megaloblastic anemia of the puerperium: An unusual cause
por: Pahadiya, Hans Raj, et al.
Publicado: (2017)

Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts
por: Martín, Iván, et al.
Publicado: (2017)

New developments in the understanding and diagnosis of myelodysplastic syndromes with ring sideroblasts()
por: Ribeiro, Lorena Bedotti, et al.
Publicado: (2016)

Anemia with thrombocytosis in an elderly male: a case of myelodysplastic syndrome-myeloproliferative neoplasm with ringed sideroblasts and thrombocytosis
por: Kumar, Ashutosh, et al.
Publicado: (2018)

Comment: In Response to “Auer Rod-Like Inclusions in Reactive Plasma Cells in a Case of Acute Myeloid Leukemia”
por: Gajendra, Smeeta
Publicado: (2016)

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts
por: Zeidan, Amer M., et al.
Publicado: (2022)

Flower-Like Plasma Cell: A Comment
por: Gajendra, Smeeta
Publicado: (2021)

Refractory anemia with ring sideroblasts and thrombocytosis
por: Pradhan, Sarita
Publicado: (2017)

Comment: In Response to “CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML”
por: Gajendra, Smeeta
Publicado: (2020)

MLASA-1: A Rare Cause of Myopathy with Sideroblastic Anemia
por: Sait, Benazer, et al.
Publicado: (2022)

Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia
por: Kjelland, Jacob D., et al.
Publicado: (2017)

Biallelic mutations in the SARS2 gene presenting as congenital sideroblastic anemia
por: Colin, Elia, et al.
Publicado: (2021)

A Novel ALAS2 Mutation Causes Congenital Sideroblastic Anemia
por: Ding, Yuxi, et al.
Publicado: (2023)

Histopathological evaluation of the bone marrow in refractory anemia with ring sideroblasts and thrombocytosis associated to the JAK2-V617F mutation
por: Duarte, Fernando Barroso, et al.
Publicado: (2014)

Cochlear implant and thiamine-responsive megaloblastic anemia syndrome
por: Hagr, Abdulrahman Abdullah
Publicado: (2014)

Dyserythropoiesis and myelodysplasia in thiamine‐responsive megaloblastic anemia syndrome
por: Faraji‐Goodarzi, Mojgan, et al.
Publicado: (2020)

JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia
por: Jekarl, Dong Wook, et al.
Publicado: (2010)

The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts
por: Kang, Min-Gu, et al.
Publicado: (2015)

Immune Complex Glomerulonephritis in a Patient with Myelodysplastic Syndrome with Ring Sideroblasts Treated with Luspatercept
por: Delanghe, Sigurd, et al.
Publicado: (2022)

Refractory anemia with ring sideroblasts in a young individual
por: Cho, Jin-Hee, et al.
Publicado: (2010)

Low-level somatic JAK2 V617F mutation in myelodysplastic/ myeloproliferative neoplasm with ring sideroblasts, and thrombocytosis with co-mutated SF3B1 and CALR
por: Ji, Young Sok, et al.
Publicado: (2022)

Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
por: Divoux, Marion, et al.
Publicado: (2020)

When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms
por: Girard, Sandrine, et al.
Publicado: (2022)

Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts
por: Platzbecker, Uwe, et al.
Publicado: (2023)

Fatal Covid-19 in a Malnourished Child with Megaloblastic Anemia
por: Kulkarni, Rajesh K., et al.
Publicado: (2020)

Five‐day regimen of azacitidine for lower‐risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single‐arm phase 2 trial
por: Morita, Yasuyoshi, et al.
Publicado: (2018)

Esophageal Leiomyoma in Patients with Megaloblastic Anemia
por: Coskun, Adil, et al.
Publicado: (2014)

Mechanism of megaloblastic anemia combined with hemolysis
por: Wu, Qiong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gpv3t5n872tb66dgsv52g0v3kd